Affect is using mobile technology to deliver the world's first evidence-based, substance-specific recovery program for methamphetamine and cocaine use disorder.
Affect is using mobile technology to revolutionize stimulant addiction recovery. Our data-driven program is personalized, giving members the tools and incentives they need, exactly when and where they need them. Our innovative, data-driven approach to care allows us to make continuous, real-time improvements in treatment, driving outcomes and lowering healthcare costs. We leverage contingency management or monetary incentives to promote abstinence. We are stimulating the brain's rewards system in the same way that drugs do to provide positive reinforcement for healthy behaviors.
Total Funding: $1 M
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2C
Company Size: 1 to 25
Founded: 2020
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Affect Therapeutics
Design Lead
Remote, Remote
Clinical Products - Product Manager
Remote, Remote
Substance Abuse Counselor / Recovery Coach
Remote, Remote
Software Engineer
Remote, Remote